SecBot SecBot
SECBOTREPLAY Home › Report › INSM

INSM · Insmed reported Q1 2026 total revenue of $306.0M (up 230% YoY, driven…

INSMED Inc · 8-K filed May 7, 2026 at 07:01 ET

At the news

BULLISHIMPACT 6/10

8-K filed May 7, 2026 at 07:01 ET

Insmed reported Q1 2026 total revenue of $306.0M (up 230% YoY, driven by BRINSUPRI launch) and a net loss of $163.6M ($0.76 per share), beating consensus EPS of -$0.90. The company reiterated 2026 BRINSUPRI revenue guidance of at least $1B and ARIKAYCE guidance of $450-470M, and highlighted positive ENCORE Phase 3b results. The stronger-than-expected launch trajectory and EPS beat are positive catalysts.

  • Total Q1 2026 revenue: $306.0M vs $92.8M in Q1 2025 (+230% YoY)
  • BRINSUPRI revenue: $207.9M (+44% vs Q4 2025)
  • ARIKAYCE revenue: $98.1M (+6% vs Q1 2025)
  • Net loss: $163.6M ($0.76 per share) vs $256.6M ($1.42) in Q1 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access